← Eichor
Study identifier: NCT04124120 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Condition: Heart Diseases · Coronary Artery Disease · Coronary Artery Bypass Grafting  ·  Sponsor: Weill Medical College of Cornell University

PhaseNA
Planned participants2300
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and cerebrovascular events in women undergoing coronary artery bypass grafting (CABG). The investigators will compare major adverse cardiac and cerebrovascular events (death, stroke, non-procedural myocardial infarction, repeat revascularization, and hospital readmission for acute coronary syndrome or heart failure) in a cohort of 2,300 women randomized 1:1 to MAG or SAG. Differences by important clinical and surgical subgroups (patients younger or older than 70 years, diabetics, racial and ethnic minorities, on vs off pump CABG, type of arterial grafts used) will also be evaluated. The women enrolled in the ongoing ROMA trial (anticipated to be approximately 690) will be included in ROMA:Women, increasing efficiency and reducing enrollment time. Hypothesis 1.0. MAG will reduce the incidence of major adverse cardiac and cerebrovascular events. Hypothesis 1.1. The improvement with MAG will be consistent across key subgroups. Aim 2: Determine the impact of MAG vs SAG on generic and disease-specific QOL, physical and mental health symptoms in women undergoing CABG. The investigators will compare generic (SF-12, EQ-5D) and disease-specific (Seattle Angina Questionnaire) QOL and physical…

This description comes directly from the study's public registry record.

Talk to the study team

Mario Gaudino, Prof/PhD/MD  ·  212.746.1812  ·  mfg9004@med.cornell.edu

Stephen Fremes, Prof/MD  ·  1 416 480 6073  ·  stephen.fremes@sunnybrook.ca

Always discuss trial participation with your own doctor first.

Locations (146)

Cedars-Sinai Medical CenterLos Angeles, California, United StatesRecruiting
Pomona Valley Hospital Medical CenterPomona, California, United StatesRecruiting
University of California, San FranciscoSan Francisco, California, United StatesRecruiting
University of ColoradoAurora, Colorado, United StatesRecruiting
Hartford HospitalHartford, Connecticut, United StatesRecruiting
Yale University HospitalNew Haven, Connecticut, United StatesRecruiting
Emory UniversityAtlanta, Georgia, United StatesRecruiting
University of ChicagoChicago, Illinois, United StatesRecruiting
Indiana UniversityIndianapolis, Indiana, United StatesRecruiting
University of IowaIowa City, Iowa, United StatesRecruiting
Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting
Baystate HealthSpringfield, Massachusetts, United StatesRecruiting

+ 134 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04124120